Usa Britain France city Sanofi confidence stress initiative Usa Britain France city Sanofi

Sanofi and GSK Began Human Trials of Protein-Based COVID-19 Vaccine

The partnership of French drugmaker Sanofi S.A. (Sanofi) and Britain’s GlaxoSmithKline Plc (GSK) entered the global race for finding a COVID-19 vaccine as they declared to have started a human trial of their vaccine on Thursday, September 3, 2020.

As explained by the press release by Sanofi, the clinical trial is currently in Phase 1/2 study and the result is expected by December this year.These two world’s leading drug makers have signed a letter of intent to enter into a collaboration in mid-April 2020 to develop an adjuvanted COVID-19 vaccine, by combining their innovative technologies.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles